Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors.
Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body’s immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.
Get a Sample report at https://www.marketresearchfuture.com/sample_request/566 .
Key players profiled in the report are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, F. Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co., Inc., Novartis,Pfizer Inc. and others.
The global Cancer Biological Therapy market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Global cancer biological therapy market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. Majorly due to recent developments in healthcare and improving economies. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better cancer treatment in the countries.
Another driver is the changing lifestyle and increasing smoking population in Middle East & Africa. It was also noted that, smoking population in Middle East has increased rapidly. For instance, between 1990 and 2012, rates of smoking in Lebanon have increased nearly by 500%. In fact, a study in the Economist pointed out that in 2012, the average Lebanese person smoked 2,379 cigarettes.
The critical restraints include high cost of cancer biological therapy and the risks involved in the treatment. The poor rate of healthcare insurance penetration in developing regions is also a drag on the market.
Get a discount at https://www.marketresearchfuture.com/check-discount/566
List of Table
TABLE 1 GLOBAL CANCER BIOLOGICAL THERAPY MARKET, BY TYPE, 2014-2023 (USD MILLION) 23
TABLE 2 MONOCLONAL ANTIBODIES FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION, 2014-2023 (USD MILLION) 24
TABLE 3 INTERFERONS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION) 25
TABLE 4 INTERLEUKINS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION) 26
TABLE 5 CANCER GROWTH INHIBITORS FOR CANCER BIOLOGIC THERAPY MARKET, BY REGION 2014-2023 (USD MILLION) 27
TABLE 6 GENE THERAPY FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION) 28
TABLE 7 COLONY STIMULATING FACTOR FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION) 29
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –